Co-founder/CEO
Neosens
NEOSENS develops an AI-based point-of-care diagnostic assistant that generates an accurate sepsis score from a drop of blood, providing results in 30 minutes. This technology addresses the issue of overdiagnosis and unnecessary antibiotic treatment in 12% of newborns in low and middle-income countries, reducing treatment duration by approximately two-thirds and cutting costs by 38%.
- Artificial Intelligence
- Digital Health
- Healthcare Technology
- Software Only
Updated 7 months ago
Funding
Raised to date
$20KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- NEOSENS develops an AI-based point-of-care diagnostic assistant that generates an accurate sepsis score from a drop of blood, providing results in 30 minutes. This technology addresses the issue of overdiagnosis and unnecessary antibiotic treatment in 12% of newborns in low and middle-income countries, reducing treatment duration by approximately two-thirds and cutting costs by 38%.